Axa’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-215,204
Closed -$22M 1562
2014
Q4
$22M Buy
215,204
+5,311
+3% +$509K 0.09% 245
2014
Q3
$18.2M Sell
209,893
-22,570
-10% -$2M 0.08% 274
2014
Q2
$21M Sell
232,463
-11,261
-5% -$842K 0.09% 258
2014
Q1
$18M Buy
243,724
+38,486
+19% +$2.68M 0.08% 273
2013
Q4
$14M Sell
205,238
-26,627
-11% -$1.73M 0.06% 309
2013
Q3
$14.1M Buy
231,865
+6,847
+3% +$418K 0.07% 289
2013
Q2
$12.5M Buy
+225,018
New +$13M 0.07% 292

Axa's COV Position: Q1 2015 in Review

Axa sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 215,204 shares — an estimated $22M sold.

Axa first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $22M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Axa reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Axa sold 215,204 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $22M.
  • Axa first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Axa's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $22M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.